Abstract
Aerosolized therapies have been used in everyday clinical practice for decades. Experimentation with different delivery systems have led to the creation of aerosolized insulin, antibiotics, gene therapy and chemotherapy. Several of these therapies are already clinically available while others are being investigated in active clinical trials. The main factors affecting the efficiency and safety of the aerosolized therapies are the production of the aerosol, distribution/deposition of the aerosol throughout the lung parenchyma, respiratory defense mechanisms and tissue/pharmaceutical molecule interactions. Current methods of aerosol production and distribution will be presented along with an overview of the respiratory defense mechanisms. In addition, methods of aerosol evaluation in conjunction with a future perspective of the potential development of aerosol therapies will be presented.
Keywords: Respiratory system, defense mechanisms, aerosol, dry powder, inhalers.
Medicinal Chemistry
Title:Defense Mechanisms of the Respiratory System and Aerosol Production Systems
Volume: 10 Issue: 2
Author(s): Paul Zarogoulidis, Kaid Darwiche, Lonny Yarmus, Dionysios Spyratos, Nevena Secen, Wolfgang Hohenforst-Schmidt, Nikolaos Katsikogiannis, Haidong Huang, Andreas Gschwendtner and Konstantinos Zarogoulidis
Affiliation:
Keywords: Respiratory system, defense mechanisms, aerosol, dry powder, inhalers.
Abstract: Aerosolized therapies have been used in everyday clinical practice for decades. Experimentation with different delivery systems have led to the creation of aerosolized insulin, antibiotics, gene therapy and chemotherapy. Several of these therapies are already clinically available while others are being investigated in active clinical trials. The main factors affecting the efficiency and safety of the aerosolized therapies are the production of the aerosol, distribution/deposition of the aerosol throughout the lung parenchyma, respiratory defense mechanisms and tissue/pharmaceutical molecule interactions. Current methods of aerosol production and distribution will be presented along with an overview of the respiratory defense mechanisms. In addition, methods of aerosol evaluation in conjunction with a future perspective of the potential development of aerosol therapies will be presented.
Export Options
About this article
Cite this article as:
Zarogoulidis Paul, Darwiche Kaid, Yarmus Lonny, Spyratos Dionysios, Secen Nevena, Hohenforst-Schmidt Wolfgang, Katsikogiannis Nikolaos, Huang Haidong, Gschwendtner Andreas and Zarogoulidis Konstantinos, Defense Mechanisms of the Respiratory System and Aerosol Production Systems, Medicinal Chemistry 2014; 10 (2) . https://dx.doi.org/10.2174/157340641130900041
DOI https://dx.doi.org/10.2174/157340641130900041 |
Print ISSN 1573-4064 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6638 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Redox Control of Cardiovascular Homeostasis by Angiotensin II
Current Pharmaceutical Design Role of AGEs-RAGE System in Cardiovascular Disease
Current Pharmaceutical Design Use of Antiplatelet Drugs in the Treatment of Acute Coronary Syndromes
Cardiovascular & Hematological Disorders-Drug Targets AMP-Activated Protein Kinase: Structure and Regulation
Current Protein & Peptide Science Patent Selections
Recent Patents on Cardiovascular Drug Discovery Hepatic Cytochrome P450 Regulation in Disease States
Current Drug Metabolism Statins: An Under-Appreciated Asset for the Prevention and the Treatment of NAFLD or NASH and the Related Cardiovascular Risk
Current Vascular Pharmacology In vivo Phenotyping Methods: Cytochrome P450 Probes with Emphasis on the Cocktail Approach
Current Pharmaceutical Design Medical Nanorobot Architecture Based on Nanobioelectronics
Recent Patents on Nanotechnology Role of Opioid Antagonists in the Treatment of Women with Glucoregulation Abnormalities
Current Pharmaceutical Design Clinical Pharmacotherapy for Obesity: Current Drugs and Those in Advanced Development
Current Drug Targets The Use of Capillary Electrochromatography for Natural Product Analysis – Theoretical Background and Recent Applications
Current Organic Chemistry Sleep Loss and Hypertension: A Systematic Review
Current Pharmaceutical Design Calcium Channel Mutations in Cardiac Arrhythmia Syndromes
Current Molecular Pharmacology Obesity, Metabolic Syndrome and the Risk of Microvascular Complications in Patients with Diabetes mellitus
Current Pharmaceutical Design Metal Ion Leachates and the Physico-Chemical Stability of Biotherapeutic Drug Products
Current Pharmaceutical Design Recent Advances in Antigen-Based Generation of Monoclonal Antibodies
Current Immunology Reviews (Discontinued) Effects of Exercise on Physical and Mental Health, and Cognitive and Brain Functions in Schizophrenia: Clinical and Experimental Evidence
CNS & Neurological Disorders - Drug Targets Renin-Angiotensin Antagonists: Therapeutic Effects Beyond Blood Pressure Control?
Current Pharmaceutical Design Disruption of Circadian Rhythms in Critical Illness - A Role of Hyperoxia-Induced Lung Injury
Current Pharmaceutical Design